Form 4: Molina Healthcare COO James Woys Reports Stock Transactions
SEC Form 4 Filing
James Woys, Chief Operating Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
Summary
- James Woys, the Chief Operating Officer of Molina Healthcare, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On March 1, 2025, Woys acquired 9,316 shares of common stock at $301.12 per share as settlement of performance stock units granted on March 1, 2022.
- He also disposed of 3,401 shares and 1,599 shares to cover withholding taxes related to the vesting of performance stock units.
- Additionally, Woys acquired 6,248 shares of restricted stock at a volume-weighted average price of $288.12 under the company's 2019 Equity Incentive Plan.
- Following these transactions, Woys beneficially owns 64,246 shares.
- The restricted stock grant vests in one-third increments on March 1, 2026, March 1, 2027, and March 1, 2028.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports stock transactions, which are a normal part of executive compensation. The vesting of performance stock units suggests positive company performance, but the tax-related disposals are neutral.
Positives
- The acquisition of shares through performance stock units indicates achievement of company performance goals.
- The grant of restricted stock aligns executive interests with long-term shareholder value.
Future Outlook
The document outlines the vesting schedule for the restricted stock, indicating future vesting events on March 1, 2026, March 1, 2027, and March 1, 2028.
Industry Context
Form 4 filings are standard practice for reporting insider transactions, providing transparency to the market regarding the buying and selling activities of company executives and directors.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards like performance stock units and restricted stock to align management's interests with those of shareholders.
- Vesting schedules for restricted stock are typically structured over a period of several years to incentivize long-term commitment and performance.
- Tax withholding obligations upon vesting of equity awards are a common occurrence, leading to the disposal of shares to cover these liabilities.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and ownership.
- The vesting of performance stock units may be viewed positively by shareholders as it reflects the achievement of company performance goals.
Key Dates
| Date | Description |
|---|---|
| 2018-05-08 | Date of Limited Power of Attorney for Section 16(a) Filings |
| 2022-03-01 | Grant date of performance stock units that vested on March 1, 2025 |
| 2025-03-01 | Date of stock transactions: acquisition of shares from performance stock units, disposal for tax withholding, and grant of restricted stock |
| 2025-02-28 | Closing price of Molina Healthcare's common stock used for valuation of performance stock units |
| 2026-03-01 | First vesting date for one-third of the newly granted restricted stock |
| 2027-03-01 | Second vesting date for one-third of the newly granted restricted stock |
| 2028-03-01 | Final vesting date for one-third of the newly granted restricted stock |
| 2025-03-04 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.